Abstract
The composition and antifungal activity of the essential oil (EO) of Angelica major and its main components α-pinene and cis-β-ocimene against clinically relevant yeasts and moulds were evaluated. EO from the plant’s aerial parts was obtained by hydrodistillation and analysed by gas chromatography (GC) and gas chromatography/mass spectrometry (GC/MS). The oil showed high contents of α-pinene (21.8 %) and cis-β-ocimene (30.4 %). Minimum inhibitory concentrations (MICs) were measured according to the broth macrodilution protocols by the Clinical and Laboratory Standards Institute (CLSI). The EO, α-pinene and cis-β-ocimene displayed low MICs and minimum fungicidal concentrations (MFCs) against dermatophytes and Cryptococcus neoformans, with α-pinene being the most active. Regarding Candida species, the EO susceptibility profiles seem to be diverse and not correlated with fluconazole susceptibility patterns. Moreover, an inhibition of yeast–mycelium transition was demonstrated at sub-inhibitory concentrations of the EO, α-pinene and cis-β-ocimene in C. albicans. In addition, their haemolytic activity was low. The activity displayed by A. major EO and its main components associated with low cytotoxic activity confirms their potential as an antifungal agent against fungal species frequently implicated in human mycoses, particularly cryptococcosis and dermatophytosis. The association with commercial antifungal compounds could bring benefits, by the effect on germ tube formation, and be used in mucocutaneous candidiasis treatment.
Similar content being viewed by others
References
Richardson M, Lass-Flörl C (2008) Changing epidemiology of systemic fungal infections. Clin Microbiol Infect 14:5–24
Pappas PG, Kauffman CA, Andes D, Benjamin DK Jr, Calandra TF, Edwards JE Jr, Filler SG, Fisher JF, Kullberg BJ, Ostrosky-Zeichner L, Reboli AC, Rex JH, Walsh TJ, Sobel JD; Infectious Diseases Society of America (2009) Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis 48:503–535
Achkar JM, Fries BC (2010) Candida infections of the genitourinary tract. Clin Microbiol Rev 23:253–273
de Pauw BE, Picazo JJ (2008) Present situation in the treatment of invasive fungal infection. Int J Antimicrob Agents 32:S167–S171
Pfaller MA (2012) Antifungal drug resistance: mechanisms, epidemiology, and consequences for treatment. Am J Med 125:S3–S13
Denning DW, Hope WW (2010) Therapy for fungal diseases: opportunities and priorities. Trends Microbiol 18:195–204
Rapp RP (2004) Changing strategies for the management of invasive fungal infections. Pharmacotherapy 24:4S–28S
Ekiert H (2000) Medicinal plant biotechnology: the Apiaceae family as the example of rapid development. Pharmazie 55:561–567
Castroviejo S (2003) Flora Ibérica, vol X. CSIC, Madrid
Council of Europe (1997) European pharmacopoeia, 3rd edn. Council of Europe, Strasbourg
Joulain D, Koenig WA (1998) The atlas of spectral data of sesquiterpene hydrocarbons. E.B.-Verlag, Hamburg
Adams RP (2004) Identification of essential oil components by gas chromatography/quadrupole mass spectroscopy. Allured Publishing Corporation, Carol Stream
Clinical and Laboratory Standards Institute (CLSI) (2008) Reference method for broth dilution antifungal susceptibility testing of yeasts; Approved standard—Third edition. CLSI document M27-A3. CLSI, Wayne
Clinical and Laboratory Standards Institute (CLSI) (2008) Reference method for broth dilution antifungal susceptibility testing of yeasts; Informational supplement—Third edition. CLSI document M27-S3. CLSI, Wayne
Clinical and Laboratory Standards Institute (CLSI) (2008) Reference method for broth dilution antifungal susceptibility testing of conidium-forming filamentous fungi; Approved standard—Second edition. CLSI document M38–A2. CLSI, Wayne
Marichal P, Gorrens J, Van Cutsem J, Vanden Bossche H (1986) Culture media for the study of the effects of azole derivatives on germ tube formation and hyphal growth of C. albicans. Mykosen 29:76–81
Ahmad A, Khan A, Manzoor N, Khan LA (2010) Evolution of ergosterol biosynthesis inhibitors as fungicidal against Candida. Microb Pathog 48:35–41
Saville SP, Lazzell AL, Bryant AP, Fretzen A, Monreal A, Solberg EO, Monteagudo C, Lopez-Ribot JL, Milne GT (2006) Inhibition of filamentation can be used to treat disseminated candidiasis. Antimicrob Agents Chemother 50:3312–3316
Nivinskienë O, Butkienë R, Mockutë D (2003) Changes in the chemical composition of essential oil of Angelica archangelica L. roots during storage. Chemija (Vilnius) 14:52–56
Kerrola K, Galambosi B, Kallio H (1994) Characterization of volatile composition and odor of angelica (Angelica archangelica subsp. archangelica L.) root extracts. J Agric Food Chem 42:1979–1988
Agnihotri VK, Thappa RK, Meena B, Kapahi BK, Saxena RK, Qazi GN, Agarwal SG (2004) Essential oil composition of aerial parts of Angelica glauca growing wild in North-West Himalaya (India). Phytochemistry 65:2411–2413
Seo HY, Yang SH, Shim SL, No KM, Park KS, Song KD, Kim KS (2007) Volatile organic compounds of Angelica gigas Nakai, Korean medicinal herb. Nat Prod Res 21:265–273
Mendes MD, Trindade H, Figueiredo AC, Barroso JG, Fontinha SS, Pedro LG (2009) Volatile and molecular characterization of two Portuguese endemic species: Angelica lignescens and Melanoselinum decipiens. Biochem Syst Ecol 37:98–105
Zuzarte M, Vale-Silva L, Gonçalves MJ, Cavaleiro C, Vaz S, Canhoto J, Pinto E, Salgueiro L (2012) Antifungal activity of phenolic-rich Lavandula multifida L. essential oil. Eur J Clin Microbiol Infect Dis 31:1359–1366
Pinto E, Hrimpeng K, Lopes G, Vaz S, Gonçalves MJ, Cavaleiro C, Salgueiro L (2013) Antifungal activity of Ferulago capillaris essential oil against Candida, Cryptococcus, Aspergillus and dermatophyte species. Eur J Clin Microbiol Infect Dis 32:1311–1320
Zuzarte M, Gonçalves MJ, Cavaleiro C, Canhoto J, Vale-Silva L, Silva MJ, Pinto E, Salgueiro L (2011) Chemical composition and antifungal activity of the essential oils of Lavandula viridis L’Hér. J Med Microbiol 60:612–618
Cavaleiro C, Pinto E, Gonçalves MJ, Salgueiro L (2006) Antifungal activity of Juniperus essential oils against dermatophyte, Aspergillus and Candida strains. J Appl Microbiol 100:1333–1338
Gupta AK, Cooper EA (2008) Update in antifungal therapy of dermatophytosis. Mycopathologia 166:353–367
Tavares AC, Gonçalves MJ, Cruz MT, Cavaleiro C, Lopes MC, Canhoto J, Salgueiro LR (2010) Essential oils from Distichoselinum tenuifolium: chemical composition, cytotoxicity, antifungal and anti-inflammatory properties. J Ethnopharmacol 130:593–598
Rivas da Silva AC, Lopes PM, Barros de Azevedo MM, Costa DC, Alviano CS, Alviano DS (2012) Biological activities of α-pinene and β-pinene enantiomers. Molecules 17:6305–6316
Nissen L, Zatta A, Stefanini I, Grandi S, Sgorbati B, Biavati B, Monti A (2010) Characterization and antimicrobial activity of essential oils of industrial hemp varieties (Cannabis sativa L.). Fitoterapia 81:413–419
Filipowicz N, Kamiński M, Kurlenda J, Asztemborska M, Ochocka JR (2003) Antibacterial and antifungal activity of juniper berry oil and its selected components. Phytother Res 17:227–231
Mitchell AP (1998) Dimorphism and virulence in Candida albicans. Curr Opin Microbiol 1:687–692
Acknowledgements
The authors are grateful to Fundação para a Ciência e a Tecnologia (FCT) through grants PEst-OE/SAU/UI0177/2011 and CEQUIMED-PEst-OE/SAU/UI4040/2014.
The Microbiology Department, Faculty of Science, Burapha University, Thailand is acknowledged for collaboration with the Lotus—Erasmus Mundus Action Two Partnership (EMA2) of European and South-East Asian Higher Education Institutions (HEI).
Thanks are also due to Dra Ana Cristina Tavares (CEF/Faculty of Pharmacy, University of Coimbra) for her help in prospecting plant material.
Conflict of interest
The authors declare no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Cavaleiro, C., Salgueiro, L., Gonçalves, MJ. et al. Antifungal activity of the essential oil of Angelica major against Candida, Cryptococcus, Aspergillus and dermatophyte species. J Nat Med 69, 241–248 (2015). https://doi.org/10.1007/s11418-014-0884-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11418-014-0884-2